DRW8 Drägerwerk AG & Co. KGaA

97.62USD89.00 EUR · XETRA-0.45%Mkt Cap: 1.83B USDP/E: 9.87

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, p…

Institutional holders10 on file

Key Statistics

Company
Market Cap1.83B USD
Enterprise Value1.95B USD
Revenue (TTM)3.94B USD
Gross Profit1.73B USD
Net Income (TTM)153.00M USD
Revenue/Share210.66 USD
Last Price97.62 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees16.7K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINDE0005550602
Valuation
P/E (Trailing)9.87
P/E (Forward)12.63
PEG1.94
EV/EBITDA5.23
EV/Revenue0.49
P/S0.46
P/B0.98
EPS (TTM)9.89 USD
EPS (Forward)7.73 USD
52W Range
60.9883% of range105.29
52W High105.29 USD
52W Low60.98 USD
Profitability
Gross Margin45.22%
Oper. Margin7.08%
EBITDA Margin9.44%
Profit Margin4.01%
ROE8.58%
ROA4.41%
ROIC8.59%
ROCE10.44%
Growth
Revenue Growth2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF261.40M USD
CapEx (TTM)88.49M USD
FCF Margin4.50%
FCF Yield9.68%
Net Debt101.10M USD
Net Debt/EBITDA0.27
Net Debt/FCF0.57
Balance Sheet
Debt/Equity0.25
Current Ratio2.07
Quick Ratio1.13
Book Value/Sh99.31 USD
Cash/Share15.73 USD
Dividends
Fwd Div Rate2.42 USD
Trail. Div Rate2.49 USD
Div. Yield2.66%
5Y Avg Yield0.57%
Payout Ratio24.50%
Ex-Div DateMay 11, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)97.62 USD
Upside (mean)+0.0%
Target Range97.62 USD – 97.62 USD
# Analysts1
Ownership
Shares Out.10.16M
Float11.56M
Insiders71.62%
Institutions8.90%
Technical
SMA 5090.98 (+7.3%)
SMA 20083.63 (+16.7%)
Beta0.56
S&P 52W Chg12.00%
Avg Vol (30d)5.45K
Avg Vol (10d)3.46K
Technical Indicators
RSI (14)65.3
MACD1.6417
MACD Signal-0.0031
MACD Hist.+1.6447
BB Upper97.84 USD
BB Middle86.87 USD
BB Lower75.89 USD
BB Width25.27%
ATR (14)3.660 USD
Vol Ratio (20d)1.01x

About Drägerwerk (ETR: DRW8)

›

Drägerwerk (ETR: DRW8) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 16,716 employees.

The shares were at 89.00 EUR on 19 November 2026, up 45.9% over 52 weeks. Its 52-week range is 55.60 EUR to 96.00 EUR: the price is 7.3% below the high and 60.1% above the low.

At a market capitalisation of 1.67B EUR, it trades at 9.9 times trailing earnings and 12.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 61% for DRW8. It pays a dividend yielding 2.66% (it pays out 25% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Drägerwerk reports return on equity of 8.6%, an operating margin of 7.1% and revenue up 2.1% year over year.

Its debt exceeds its cash by 92.17M EUR, a debt-to-equity ratio of 0.25. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 89.00 EUR is 0.0% above the current price.